A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission

NCT00808509 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

BIOLOGICAL: adalimumab
DRUG: methotrexate

Sponsor

AbbVie (prior sponsor, Abbott)

Collaborators

[object Object]